Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07572227
Fetal Cystoscopy in the Management of Lower Urinary Tract Obstruction (LUTO)Mayo ClinicEnrolling By InvitationNot Applicable
NCT07572227Enrolling By Invitation
Not Applicable
Fetal Cystoscopy in the Management of Lower Urinary Tract Obstruction (LUTO)Mayo Clinic
NCT07574411
Effects of E-care Protocol in Patients With Coronary Artery Bypass GraftRiphah International UniversityNot Yet RecruitingNot Applicable
NCT07574411Not Yet Recruiting
Not Applicable
Effects of E-care Protocol in Patients With Coronary Artery Bypass GraftRiphah International Univ...
NCT07572097
High-Frequency Irreversible Electroporation vs Standard of Care for Benign Prostatic HyperplasiaShanghai East HospitalNot Yet RecruitingNot Applicable
NCT07572097Not Yet Recruiting
Not Applicable
High-Frequency Irreversible Electroporation vs Standard of Care for Benign Prost...Shanghai East Hospital
NCT07573839
An Exploratory Study on the Prediction of Recurrence Risk of Bipolar Disorder Using Sentiment Analysis Technology Based on Multi-modal Feature FusionShanghai Mental Health CenterRecruiting
NCT07573839Recruiting
—
An Exploratory Study on the Prediction of Recurrence Risk of Bipolar Disorder Us...Shanghai Mental Health Ce...
NCT07574138
Function of Beta Cells in Early-onset Diabetes MellitusUniversity Medical Center Ho Chi Minh City (UMC)Recruiting
NCT07574138Recruiting
—
Function of Beta Cells in Early-onset Diabetes MellitusUniversity Medical Center...
NCT07573696
Multidisciplinary Treatment of Stage III ALK+ NSCLC With Neoadjuvant Alectinib and ChemotherapyWen-zhao ZHONGNot Yet RecruitingPhase 2
NCT07573696Not Yet Recruiting
Phase 2
Multidisciplinary Treatment of Stage III ALK+ NSCLC With Neoadjuvant Alectinib a...Wen-zhao ZHONG
NCT07573241
Single Arm Trial Identifying Barriers and Facilitators to Mindfulness PracticeNational Center for Complementary and Integrative Health (NCCIH)Not Yet RecruitingNot Applicable
NCT07573241Not Yet Recruiting
Not Applicable
Single Arm Trial Identifying Barriers and Facilitators to Mindfulness PracticeNational Center for Compl...
NCT07573072
Characterization of the Methylation Profile of Stored Human SamplesIstituto Ortopedico RizzoliCompleted
NCT07573072Completed
—
Characterization of the Methylation Profile of Stored Human SamplesIstituto Ortopedico Rizzo...
NCT07574359
RUSS-AGE: Creating of a Biological Age Calculator and Study of Aging Phenotypes in the Russian PopulationPirogov Russian National Research Medical UniversityRecruiting
NCT07574359Recruiting
—
RUSS-AGE: Creating of a Biological Age Calculator and Study of Aging Phenotypes...Pirogov Russian National...
NCT07573644
A Prospective Randomized Study Comparing the Safety of Percutaneous and Open Brachial Access in the Endovascular Treatment of Peripheral Arterial LesionUniversity Hospital, BrestNot Yet RecruitingNot Applicable
NCT07573644Not Yet Recruiting
Not Applicable
A Prospective Randomized Study Comparing the Safety of Percutaneous and Open Bra...University Hospital, Bres...
NCT07573293
BPTB Versus Hamstring Autografts in ACL Reconstruction Among Professional AthletesCairo UniversityCompletedNot Applicable
NCT07573293Completed
Not Applicable
BPTB Versus Hamstring Autografts in ACL Reconstruction Among Professional Athlet...Cairo University
NCT07573514
Patients With Primary Biliary CholangitisFondazione Policlinico Universitario Agostino Gemelli IRCCSActive Not RecruitingNot Applicable
NCT07573514Active Not Recruiting
Not Applicable
Patients With Primary Biliary CholangitisFondazione Policlinico Un...
NCT07572123
Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treatment of Chemotherapy and Autologous Stem Cell Transplant Alone for High-risk Patients With Relapsed or Refractory Hodgkin LymphomaNational Cancer Institute (NCI)Not Yet RecruitingPhase 2
NCT07572123Not Yet Recruiting
Phase 2
Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treat...National Cancer Institute...
NCT07572825
Assessing the Safety and Tolerability of NMN in DHDDS-CDGEva Morava-KoziczNot Yet RecruitingPhase 1
NCT07572825Not Yet Recruiting
Phase 1
Assessing the Safety and Tolerability of NMN in DHDDS-CDGEva Morava-Kozicz
NCT07574333
Effects of Short and Long Courses of Intermittent Hypoxic-Hyperoxic Training in Patients With Type 2 Diabetes Including ElderlyNational Medical Research Center for Therapy and Preventive MedicineRecruitingNot Applicable
NCT07574333Recruiting
Not Applicable
Effects of Short and Long Courses of Intermittent Hypoxic-Hyperoxic Training in...National Medical Research...
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07572136
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-cell Acute Lymphoblastic Leukemia (B-ALL)National Cancer Institute (NCI)Not Yet RecruitingPhase 1
NCT07572136Not Yet Recruiting
Phase 1
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T...National Cancer Institute...
NCT07574372
Effect of ERAS and Upper Limb Exercise on LoS After Modified Radical MastectomyProf. R. D. Kandou General HospitalCompletedNot Applicable
NCT07574372Completed
Not Applicable
Effect of ERAS and Upper Limb Exercise on LoS After Modified Radical MastectomyProf. R. D. Kandou Genera...
NCT07574281
Effectiveness and Implementation of the DINKNESH Digital Palliative Care Tool in EthiopiaAddis Ababa UniversityNot Yet RecruitingNot Applicable
NCT07574281Not Yet Recruiting
Not Applicable
Effectiveness and Implementation of the DINKNESH Digital Palliative Care Tool in...Addis Ababa University
Result Breakdown
Not yet recruiting10 (50%)
Recruiting5 (25%)
Completed3 (15%)
Enrolling by invitation1 (5%)
Active, not recruiting1 (5%)
not_applicable11 (55%)
Not Specified5 (25%)
Phase 22 (10%)
Phase 12 (10%)